Bias and Type I error Control in Correcting Treatment Effect for Treatment Switching Using Marginal Structural Models in Phase III Oncology Trials

References

• Cole S, R., and A. Hernán M. 2004 08. Adjusted survival curves with inverse probability weights. Computer Methods and Programs in Biomedicine 75 (1):45–49. doi:10.1016/j.cmpb.2003.10.004.
   PubMed Web of Science ®Google Scholar
• Cole, S. R., and C. E. Frangakis. 2009. The consistency statement in causal inference a definition or an assumption? Epidemiology 20 (1):3–5. doi:10.1097/EDE.0b013e31818ef366.
   PubMed Web of Science ®Google Scholar
• Cole, S. R., and M. A. Hernán. 2008. Constructing inverse probability weights for marginal structural models. American Journal of Epidemiology 168 (6):656–664. doi:10.1093/aje/kwn164.
   PubMed Web of Science ®Google Scholar
• D’Agostino, R. B., M. L. Lee, A. J. Belanger, L. A. Cupples, K. Anderson, and W. B. Kannel. 1990. Relation of pooled logistic regression to time dependent cox regression analysis: the Framingham heart study. Statistics in Medicine 9 (12):1501–1515. doi:10.1002/sim.4780091214.
   PubMed Web of Science ®Google Scholar
• Farmer, R. E., D. Kounali, A. S. Walker, J. Savovic, A. Richards, M. T. May, et al. 2018. Application of causal inference methods in the analyses of randomized controlled trials: A systematic review. MioMed Central 19 (23):1–14. doi:10.1186/s13063-017-2381-x.
   Google Scholar
• Hernán, M. Á., B. Brumback, and J. M. Robins. 2000. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11 (5):561–570. doi:10.1097/00001648-200009000-00012.
   PubMed Web of Science ®Google Scholar
• Hernán, M. A., B. Brumback, and J. M. Robins. 2001. Marginal structural models to estimate the joint causal effect of nonrandomized treatments. Journal of the American Statistical Association 96 (454):440–448. doi:10.1198/016214501753168154.
   Web of Science ®Google Scholar
• Holmes, M. D., W. Y. Chen, L. Li, E. Hertzmark, D. Spiegelman, and S. E. Hankinson. 2010. Aspirin intake and survival after breast cancer. Journal of Clinical Oncology 28 (9):1467–1472. doi:10.1200/JCO.2009.22.7918.
   PubMed Web of Science ®Google Scholar
• Hosmer Jr. D.W., S. Lemeshow, and S. May. 2008. Applied Survival Analysis: Regression Modeling of Time-to-Event Data. 2nd ed. Hoboken, New Jersey: John Wiley & Son's Inc., ISBN:13:978-0471754992.
   Google Scholar
• Kalbfleisch, J., and R. Prentice. 2011. The statistical analysis of failure time data. 2nd ed. Hoboken, New Jersey: published by John Wiley & Son's Inc., ISBN:13: 978-0471363576.
   Google Scholar
• Latimer, N. R., K. R. Abrams, P. C. Lambert, J. P. Morden, and M. J. Crowther. 2018. Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study. Statistical Methods in Medical Research 27 (3):765–784. doi:10.1177/0962280216642264.
   PubMed Web of Science ®Google Scholar
• Rimawi, M., and S. G. Hilsenbeck. 2012. Making sense of clinical trial data: Is inverse probability of censoring weighted analysis the answer to crossover bias. J Clin Oncol 30 (4):453–458. doi:10.1200/JCO.2010.34.2808.
   PubMed Web of Science ®Google Scholar
• Robins, J. M. 2000. Marginal structural models versus structural nested models as tools for causal inference. In Statistical models in epidemiology, the environment, and clinical trials, 95–133. New York: Springer. ISBN-13: 978-1461270782
   Google Scholar
• Robins, J. M., and D. M. Finkelstein. 2000. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 56 (3):779–788. doi:10.1111/j.0006-341X.2000.00779.x.
   PubMed Web of Science ®Google Scholar
• Robins, J. M., M. A. Hernán, and B. Brumback. 2000. Marginal structural models and causal inference in epidemiology. Epidemiology 11 (5):550–560. doi:10.1097/00001648-200009000-00011.
   PubMed Web of Science ®Google Scholar
• Rotnitzky, A., and J. Robins. 2005. Inverse probability weighted estimation in survival analysis. Encyclopedia of Biostatistics 4:2619–2625.
   Google Scholar
• Saad, F., K. Fizazi, V. Jinga, E. Efstathiou, P. C. Fong, L. L. Hart, R. Jones, R. McDermott, M. Wirth, K. Suzuki, et al. 2015. Orteronel plus prednisone in patients with chemotherapy- naive metastatic castration-resistant prostate cancer (ELM-PC 4): A double-blind, multicenter, phase 3, randomized, placebo-controlled trial. The Lancet Oncology. 16(3):338–348. doi:10.1016/S1470-2045(15)70027-6.
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. 2011. SAS 9.1 User’s Guide. Cary, NC: SAS Institute Inc., ISBN:1-59047-244-6. http://www.sas.com/
   Google Scholar
• Watkins, C., X. Huang, N. Latimer, Y. Tang, and E. Wright. 2013. Adjusting overall survival for treatment switches: Commonly used methods and practical application. Pharmaceutical Statistics 12 (6):348–357. doi:10.1002/pst.1602.
   PubMed Web of Science ®Google Scholar
• Xie, J., and C. Liu. 2005. Adjusted Kaplan–Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Statistics in Medicine 24 (20):3089–3110. https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.2174.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, T., and Y. Ohashi. 2004a. Adjusting for differential proportions of second-line treatment in cancer clinical trials. part i: structural nested models and marginal structural models to test and estimate treatment arm effects. Statistics in Medicine 23 (13):1991–2003. doi:10.1002/sim.1816.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, T., and Y. Ohashi. 2004b. Adjusting for differential proportions of second-line treatment in cancer clinical trials. part ii: an application in a clinical trial of unresectable non-small-cell lung cancer. Statistics in Medicine 23 (13):2005–2022. doi:10.1002/sim.1817.
   PubMed Web of Science ®Google Scholar
• Young, J. G., and E. J. Tchetgen Tchetgen. 2014. Simulation from a known cox MSM using standard parametric models for the g-formula. Statistics in Medicine 33 (6):1001–1014. doi:10.1002/sim.5994.
   PubMed Web of Science ®Google Scholar